[Low-dosage acetylsalicylic acid as primary prevention against cardiovascular disease].
Landmark
K
K
Institutt for farmakoterapi Postboks 1065 Blindern 0316 Oslo. k.h.landmark@ioks.uio.no
D001241:Aspirin / Q000008:administration & dosage*; D018849:Controlled Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D011322:Primary Prevention; D016032:Randomized Controlled Trials as Topic
D005343:Fibrinolytic Agents; D001241:Aspirin